Monograph Details
|
|
Respiratory Tract
> Rhinitis/rhinorrhea (intranasal products)
|
|
ATROVENT NASAL SPRAY 0.06% |
| Manufacturer |
|
Boehringer Ingelheim Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Anticholinergic. |
| Generic Name |
|
Ipratropium bromide 0.06% (42micrograms/spray); aqueous soln. |
| Indications |
|
Rhinorrhea associated with the common cold. |
| Adults and Children |
|
<5yrs: not recommended. 5–11yrs: 2 sprays in each nostril 3 times daily. ≥12yrs: 2 sprays in each nostril 3–4 times daily. |
| Contraindications |
|
Allergy to atropine or its derivatives. |
| Precautions |
|
Avoid eyes. Narrow-angle glaucoma. GI or GU obstruction. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Epistaxis, dry mouth or throat, nasal congestion or dryness. |
| How Supplied |
|
Nasal spray—15mL (165 sprays) |
|
|
|
|
